Back to Search
Start Over
(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors
- Source :
- Progress in Neuropsychopharmacology & Biological Psychiatry, 35(3), 659-663. Elsevier Inc., Maes, M, Leonard, B, Fernandez, A, Kubera, M, Nowak, G, Veerhuis, R, Gardner, A, Ruckoanich, P, Geffard, M, Altamura, C, Galecki, P & Berk, M 2011, ' (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors ', Progress in Neuropsychopharmacology & Biological Psychiatry, vol. 35, no. 3, pp. 659-663 . https://doi.org/10.1016/j.pnpbp.2011.02.019
- Publication Year :
- 2011
- Subjects :
- Drug
Neuroimmunomodulation
media_common.quotation_subject
Anti-Inflammatory Agents
MEDLINE
Inflammation
Pharmacology
Antioxidants
Neuro inflammation
Drug Discovery
Humans
Medicine
Molecular Targeted Therapy
Protein Kinase Inhibitors
Biological Psychiatry
Depression (differential diagnoses)
media_common
Depression
Drug discovery
business.industry
Kinase
Antidepressive Agents
medicine.symptom
business
Subjects
Details
- ISSN :
- 02785846
- Volume :
- 35
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Progress in Neuropsychopharmacology & Biological Psychiatry
- Accession number :
- edsair.doi.dedup.....c532002d33e242d0401193253d71396f
- Full Text :
- https://doi.org/10.1016/j.pnpbp.2011.02.019